search
Back to results

Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome (REMOTE-ACS)

Primary Purpose

Acute Coronary Syndrome

Status
Withdrawn
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Telerehabilitation (Tele RCV)
Rehabilitation (RCV)
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Acute Coronary Syndrome focused on measuring Cardiac rehabilitation, Tele-health

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with acute coronary syndrome less than 6 months,
  • Addressed to ambulatory cardiac rehabilitation,
  • Equipped with a smartphone compatible with the protocol's application, connected to web
  • Having signed an informed consent,
  • Affiliated to the french national health insurance.

Exclusion Criteria:

  • Incapacity to use application on smartphone,
  • Contraindication to exercise training,
  • Pregnancy,
  • Juridic protection
  • Left ventricular ejection fraction < 45%
  • Significate ventricular arrhythmia (frequent or polymorph PVC during initial exercise testing, ventricular tachycardia or sudden cardiac death at the beginning)
  • Flutter or atrial fibrillation (transient or permanent)
  • Coronary revascularization needing supplementary procedure
  • Residual myocardial ischemia determined by initial exercise testing or alternative testing (nuclear imaging or stress echocardiography)
  • Mini Mental State < 26
  • Patients living alone at home
  • Comorbidities limiting participation to the protocol: kidney dialysis, insulin-requiring diabetes, residuals sequels of central and/or peripheral nervous system injuries

Sites / Locations

  • Marc LABRUNEE

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Telerehabilitation (Tele RCV)

Rehabilitation (RCV)

Arm Description

Experimental group (Tele-RCV): the treatment will consist of 20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training (the first session in center to form the patient) associated with 8 educative sessions.

Group control (RCV) : 20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.

Outcomes

Primary Outcome Measures

Effect analysis 2 month after inclusion
Change of the peak oxygen volume at 2 months after inclusion

Secondary Outcome Measures

Effect analysis 1 month after inclusion
Analysis of change between T0 and 1 month concerning the walking tests : distance traveled in meters
Effect analysis 1 month after inclusion
Analysis of change between T0 and 1 month concerning the number of Tele-RCV or RCV sessions realized
Effect analysis 2 months after inclusion
Analysis of change between T0 and 2 months concerning the walking tests:distance traveled in meters
Effect analysis 2 months after inclusion
Analysis of change between T0 and 2 months concerning the number of Tele-RCV or RCV sessions realized
Health economics criteria
Incremental Cost-effectiveness ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.
Health economics criteria
Cost-utility ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.
Production cost of the REMOTE-ACS device
Production cost of the REMOTE-ACS device by micro costing, according the hospital perspective
Acceptability of the device
The acceptability will be assessed by a sociological point of view based on collective meeting (with patient and caregivers) and individual questionnaires for the two groups before randomization and after the program only for the Tele-RCV group.
Satisfaction of the device
The satisfaction will be assessed by a questionnaire of satisfaction titled: Cardiovascular rehabilitation program satisfaction questionnaire, with 8 questions, the minimum value is "nothing", and the maximum value is "very important"

Full Information

First Posted
April 21, 2020
Last Updated
July 21, 2023
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT05385341
Brief Title
Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome
Acronym
REMOTE-ACS
Official Title
Is Tele-rehabilitation an Efficacious Alternative to Traditional Center Based Cardiac Rehabilitation After Acute Coronary Syndrome?
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Withdrawn
Why Stopped
The start of the study took too long and there are already many publications on the subject
Study Start Date
September 1, 2022 (Anticipated)
Primary Completion Date
March 31, 2023 (Anticipated)
Study Completion Date
March 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Despite a clear indication of grade Ia, cardiac rehabilitation (CR) is dramatically underutilized after acute coronary syndrome with less than 30% of patients addressed in France. Mobile technology has the potential to overcome barriers to access to cardiac rehabilitation and may be a useful tool for increasing participation. However, studies have to prove this type of care is as effective as traditional center based cardiac rehabilitation.
Detailed Description
After acute coronary syndrome (ACS), it is recommended to propose a cardiac rehabilitation (CR) program in order to reduce the risk of recidive, to improve the quality of life and to reduce the risk of disabilities. Traditional CR which is most of the time center-based, is underutilized with less than 30% of patients addressed en France. Therefore, Télé-Cardiac Rehabilitation (Télé-RCV) has been developped progressively since the eighties showing comparable efficacity compared with CR concerning physical fitness. The investigative team, had previously published results showing that telephone support guided by accelerometers could improve physical activity. However, In France, device allowing telemonitoring online of heart rate are not available. Moreover, the investigators have not yet developped remote therapeutic education which is proposed in CR programs. Thus, the present study planned to develop and evaluate aTele-RCV solution aimed to monitor exercise training at home and to educate remotely patient after ACS. The device is an association of a heart rate monitor, a blood pressure testing, a balance linked with a full web secured application connecting patient and caregivers. In the intervention group, Tele-RCV is proposed during 20 sessions containing 2h of exercise training combined with 6h of therapeutic tele-education. In the control group, CR is proposed during 20 sessions with the same volume of exercise training and therapeutic education. After randomisation, patient are allocated to one of the two groups. The evaluation of the primary and secondary outcomes are realized at the beginning, at one month (only walking tests) and at 2 months. A social evaluation is done in parallel to test the acceptability for the Télé-RCV compared with CR.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Coronary Syndrome
Keywords
Cardiac rehabilitation, Tele-health

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Telerehabilitation (Tele RCV)
Arm Type
Experimental
Arm Description
Experimental group (Tele-RCV): the treatment will consist of 20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training (the first session in center to form the patient) associated with 8 educative sessions.
Arm Title
Rehabilitation (RCV)
Arm Type
Active Comparator
Arm Description
Group control (RCV) : 20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.
Intervention Type
Other
Intervention Name(s)
Telerehabilitation (Tele RCV)
Intervention Description
20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training associated with educative sessions.
Intervention Type
Other
Intervention Name(s)
Rehabilitation (RCV)
Intervention Description
20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.
Primary Outcome Measure Information:
Title
Effect analysis 2 month after inclusion
Description
Change of the peak oxygen volume at 2 months after inclusion
Time Frame
2 months
Secondary Outcome Measure Information:
Title
Effect analysis 1 month after inclusion
Description
Analysis of change between T0 and 1 month concerning the walking tests : distance traveled in meters
Time Frame
1 month
Title
Effect analysis 1 month after inclusion
Description
Analysis of change between T0 and 1 month concerning the number of Tele-RCV or RCV sessions realized
Time Frame
1 month
Title
Effect analysis 2 months after inclusion
Description
Analysis of change between T0 and 2 months concerning the walking tests:distance traveled in meters
Time Frame
2 months
Title
Effect analysis 2 months after inclusion
Description
Analysis of change between T0 and 2 months concerning the number of Tele-RCV or RCV sessions realized
Time Frame
2 months
Title
Health economics criteria
Description
Incremental Cost-effectiveness ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.
Time Frame
26 months
Title
Health economics criteria
Description
Cost-utility ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.
Time Frame
26 months
Title
Production cost of the REMOTE-ACS device
Description
Production cost of the REMOTE-ACS device by micro costing, according the hospital perspective
Time Frame
26 months
Title
Acceptability of the device
Description
The acceptability will be assessed by a sociological point of view based on collective meeting (with patient and caregivers) and individual questionnaires for the two groups before randomization and after the program only for the Tele-RCV group.
Time Frame
26 months
Title
Satisfaction of the device
Description
The satisfaction will be assessed by a questionnaire of satisfaction titled: Cardiovascular rehabilitation program satisfaction questionnaire, with 8 questions, the minimum value is "nothing", and the maximum value is "very important"
Time Frame
26 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with acute coronary syndrome less than 6 months, Addressed to ambulatory cardiac rehabilitation, Equipped with a smartphone compatible with the protocol's application, connected to web Having signed an informed consent, Affiliated to the french national health insurance. Exclusion Criteria: Incapacity to use application on smartphone, Contraindication to exercise training, Pregnancy, Juridic protection Left ventricular ejection fraction < 45% Significate ventricular arrhythmia (frequent or polymorph PVC during initial exercise testing, ventricular tachycardia or sudden cardiac death at the beginning) Flutter or atrial fibrillation (transient or permanent) Coronary revascularization needing supplementary procedure Residual myocardial ischemia determined by initial exercise testing or alternative testing (nuclear imaging or stress echocardiography) Mini Mental State < 26 Patients living alone at home Comorbidities limiting participation to the protocol: kidney dialysis, insulin-requiring diabetes, residuals sequels of central and/or peripheral nervous system injuries
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc LABRUNEE, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
Marc LABRUNEE
City
Toulouse
Country
France

12. IPD Sharing Statement

Learn more about this trial

Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome

We'll reach out to this number within 24 hrs